OTCD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

488 results for “OTCD”

Trials

View all 427 →

A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

9 participants · First posted Jul 5, 2024

Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810

8 participants · First posted Sep 2, 2022

Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI

49 participants · First posted Apr 3, 2012

Drugs

View all 11 →

BGT-OTCD

NTCD-M3

TCD-51073

Organizations

MONTEFARMACO OTC SPA

Italy

OTC Pharm LLC

United States

NEO HEALTH (OTC) PTY LTD

Australia

News

View all 47 →

Arcturus Therapeutics Poised for Growth with Cystic Fibrosis and OTCD Therapies

PL Developments Receives FDA Approval for Omeprazole OTC

rTMS Shows Promise in Treating OCD, Especially in Patients with Comorbid Depression

Page 1 of 49